CLiC Poll #2: Survey re. MURANO 48-month data presented at iwCLL conference 2019
The following questions refer to the MURANO 48-month data presented at iwCLL conference 2019, reviewed in Dr. Owen's podcast available here: http://bit.ly/361uitB
Email address *
1. Based on the MURANO 48-month data presented at iwCLL conference 2019, reviewed in Dr. Owen's podcast, should MRD testing (positive MRD) be used to tailor treatment with VR given 27% of patients who discontinued treatment have now progressed?
Please explain your answer:
Your answer
2. Based on the MURANO 48-month data, should high risk cytogenetics be used to tailor treatment with VR given 27% of patients who discontinued treatment have now progressed?
Please explain your answer:
Your answer
3. Based on the MURANO 48-month data, should everyone stop treatment at 24 months?
Please explain your answer:
Your answer
Submit
Never submit passwords through Google Forms.
This form was created inside of Sosido.com. Report Abuse